Heart-Smart cancer care: team approach tested in breast cancer patients

NCT ID NCT01621659

Ongoing Disease control Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether extra care from a team of heart doctors, dietitians, exercise therapists, pharmacists, and physiotherapists can reduce side effects in breast cancer patients receiving chemotherapy. About 80 participants will be randomly assigned to either the team intervention or usual care. The main goal is to see if this approach helps preserve heart function during and after cancer treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: multidisciplinary team intervention (cardiology, nutrition, exercise, pharmacy, physiotherapy assessments and counseling)
What this could lead to: If it works, this could show that extra support from multiple health experts reduces heart damage and improves quality of life during and after cancer treatment.
What could go wrong: This is a small, early-phase study with only 80 participants, so results may not apply to everyone. The extra care may not significantly improve outcomes over usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm lymphoma Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Cross Cancer Institute

Edmonton, Alberta, T6G 1Z2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.